F. Jehl

Université de Strasbourg — France

Medicine · Health Sciences

39h-index4.3kcitations253works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotics Pharmacokinetics and Efficacy(99), Antibiotic Resistance in Bacteria(59), Drug Transport and Resistance Mechanisms(46), Pneumonia and Respiratory Infections(26), Bacterial Identification and Susceptibility Testing(26)

Publications253 total

Should we, and how to, optimize cefiderocol administration during severe nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumanii? A viewpoint
Journal of Global Antimicrobial Resistance·2024· 3 citedOpen Access
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel
International Journal of Antimicrobial Agents·2023· 45 citedOpen Access
Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues
Clinical Pharmacokinetics·2022· 8 cited
Bactéries multirésistantes et hautement résistantes émergentes : définition et mécanismes de résistance d'intérêt épidémiologique
Revue Francophone des Laboratoires·2021· 1 cited
Erratum to: <i>In vitro</i> activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France
JAC-Antimicrobial Resistance·2021· 12 citedOpen Access
Low prevalence of tissue detection of cefepime and daptomycin used as empirical treatment during revision for periprosthetic joint infections: results of a prospective multicenter study
European Journal of Clinical Microbiology & Infectious Diseases·2021· 5 cited
<i>In vitro</i>activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France
JAC-Antimicrobial Resistance·2021· 18 citedOpen Access
A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during <i>Staphylococcus aureus</i> Bone and Joint Infections
Antimicrobial Agents and Chemotherapy·2020· 11 citedOpen Access
Prise en charge des infections chroniques de prothèses totales de hanche (PTH) et de genou (PTG) traitées par changement en un temps : quand faut-il élargir l’antibiothérapie probabiliste aux bacilles à gram négatif (BGN) ? (Étude β-SEPTIC)
Médecine et Maladies Infectieuses·2020
Improvement of a disk diffusion method for antibiotic susceptibility testing of anaerobic bacteria. French recommendations revisited for 2020
Anaerobe·2020· 27 cited
P132 Role of β-lactams in the induction of early adhesion and phenotype variation in cystic fibrosis Pseudomonas aeruginosa isolates highlighted by clinical BioFilm Ring Test
Journal of Cystic Fibrosis·2020Open Access
Clinical Impact of Antibiotics for the Treatment of Pseudomonas aeruginosa Biofilm Infections
Frontiers in Microbiology·2020· 187 citedOpen Access
L’ANTIBIOGRAMME ET SON INTERPRÉTATION EN 2018. IMPORTANCE DES CMI
ACTUALITES PERMANENTES EN MICROBIOLOGIE CLINIQUE·2019Open Access
Bone penetration of daptomycin in diabetic patients with bacterial foot infections
International Journal of Infectious Diseases·2019· 10 citedOpen Access
Breakpoint to MIC quotient: A parameter to rapidly evaluate the in vitro bactericidal activity of β-lactams on Enterobacteriaceae
International Journal of Antimicrobial Agents·2019· 7 cited
Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates
Frontiers in Microbiology·2017· 16 citedOpen Access
Staphylococcus aureus méticillino-résistants : concentrations critiques et pharmacodynamie de la vancomycine et des nouvelles céphalosporines
Journal des Anti-infectieux·2017
Kinetics of biofilm formation by Staphylococcus lugdunensis strains in bone and joint infections
Diagnostic Microbiology and Infectious Disease·2017· 19 cited
Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies
PLoS ONE·2016· 128 citedOpen Access
BACT-01 - La formation de biofilm par P. aeruginosa par les antibiotiques est inductible et réversible
Médecine et Maladies Infectieuses·2016
page 1 of 13Next →

Frequent Co-authors

H. Monteil(24), Gilles Prévost(11), P. Riegel(10), Dominique Levêque(9), C. Gallion(9), D. De Briel(8), Raymond Ruimy(5), Richard Christen(5), R Minck(4), J.M. Brogard(4), Patrice Nordmann(3), Jean‐Frédéric Blickle(3), Albert Jaeger(2), Elodie Olivares(2), Stéphanie Badel-Berchoux(2), Christian Provot(2), Thierry Bernardi(2), F. Enjalbert(2), G. Prévost(2), Élisabeth Quoix(2)